In non–small cell lung cancer (NSCLC), SPOP expression is downregulated and significantly correlated with unfavorable clinical outcomes, suggesting its potential role as a tumor suppressor gene in NSCLC (52). The gene discussed is SPOP; the disease is non-small cell lung carcinoma.